Eli Lilly partner sees growth

A Chinese biotech company developing anti-cancer drugs with Eli Lilly has urged investors to focus on future prospects and not hefty losses.

Eli Lilly partner sees growth

By Daniela Wei and Pádraig Hoare

A Chinese biotech company developing anti-cancer drugs with Eli Lilly has urged investors to focus on future prospects and not hefty losses.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited